|
|
Article: Avoid Unwanted Publicity, Raise Money When Possible: Holaday.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Washington Editor
McLEAN, Va. - It's not all gloom and doom in the biotech industry, even though 35 percent of U.S. companies have only a year's worth of cash, 90 percent of the industry's stocks are down and a number of companies are facing Nasdaq delisting after falling below the $1 bid requirement.
The industry has been through slumps before, and this recent one likely won't be the last. But there is hope on the horizon, speakers at the second annual BIO IT Coalition conference here said. The coalition is a nonprofit organization operating in the metropolitan Washington area charged with promoting the development of bioinformatics.
As ...